跳至主要内容
临床试验/IRCT20210613051565N1
IRCT20210613051565N1招募中3 期

The effect of adding Mirtazapine to quetiapine on reducing aggression in patients with Alzheimer's dementia

niversity of social welfare and rehabilitation sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Adult patients (over the age of 18)
  • With Alzheimer's dementia
  • At least two years have passed since the onset of the disease
  • Confirm by a neurologist or psychiatrist with the NIA-AA (2011 National Institute on Aging and Alzheimer's Association) diagnostic criteria assistant.
  • Participant's consent
  • Cohen-Mansfield Agitation Inventory (CMAI) test score more than 45

排除标准

  • No psychiatric disability
  • No physical disability
  • No neurological disability
  • Any disease with significant cognitive Impairment, (mental retardation)
  • No substance abuse in the previous six months
  • No extra psychiatric medication

研究者

发起方
niversity of social welfare and rehabilitation sciences

相似试验